Expiring patents are already priced in so that will have no effect on their stock price. They have a history of creating blockbuster drugs and there are more to come as they currently have 118 drugs in the pipeline. 60 of those are in phase 2 or 3.… More
Fools bullish on PFE
are also bullish on:
Not a very well run company. A science company being run by a bunch of businessmen does not produce good results. Sure the dividend and their cash is nice, but I have no confidence that Pfizer can actually achieve something scientifically viable on… More
Fools bearish on PFE
are also bearish on: